Asymptomatic carotid lesion as a marker of future cerebrovascular and cardiovascular events

Acta Chirurgica Belgica

Volumn 103, Issue 3, 2003, Pages 262-269

  Novo, S ^a,b   Corrado, E ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTITHROMBOCYTIC AGENT; ATENOLOL; ATORVASTATIN; CALCIUM ANTAGONIST; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUINDOSTATIN; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISRADIPINE; LACIPIDINE; METOPROLOL; MEVINOLIN; PRAVASTATIN; RAMIPRIL; SIMVASTATIN; UNCLASSIFIED DRUG; VERAPAMIL;

ARTERY LESION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY LESION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; ECHOGRAPHY; HEART DEATH; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTIMA; ISCHEMIC HEART DISEASE; LABORATORY TEST; POPULATION RESEARCH; REVIEW; RISK ASSESSMENT; STROKE; SYMPTOM; TRANSIENT ISCHEMIC ATTACK;

EID: 1642378193     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2003.11679420     Document Type: Review

References (32)

1. Crouse J. R. 3rd. Predictive value of carotid 2-dimensional ultrasound. Am J Cardiol, 2001, 88 : 27E-30E.
2. O'LEARY D. H., POLAK J. F., KRONMAL R. A., KITTNER S. J., BOND M. G., WOLFSON S. K., BOMMER W., PRICE T. R., GARDIN J. M., SAVAGE P. J., on behalf of the CHS Collaborative Group. Distribution and correlates of son graphically detected carotid artery disease in the Cardiovascular Health Study. Stroke, 1992, 23 : 1752-1760.
3. HERMITS ELLER N., NETTERSTROM B. The intima media thickness and coronary risk factors. Int Angiol, 2001, 20 : 118-25.
4. SALONEN J. T., SEPPANEN K., RAURAMAA R., SALONEN R. Risk factors for carotid atherosclerosis : the Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Med, 1989, 21 : 227-9.
5. Novo S. Influence of risk factors and aging on asymptomatic carotid lesion. In : Adv. Vasc. Pathol. 1997, Excerpta Medica, Amsterdam, 1997 : 36-46.
6. SALONEN R., SALONEN J. T. Determinants of carotid intima-media thickness : a population-based ultrasonography study in eastern Finnish men. Arteriosclerosis Thrombosis, 1991, 11 : 1245-1249.
7. Novo S. Carotid lesion as risk factor for ischemic heart disease. Haematologica, 2001, 86 (Suppl 2) : 12-5.
8. BOTS M. L., MOONS K. G., HOLLANDER M., HOFFMAN A., KOUDSTAAL P. J., GROBBEE D. E., BRETELER M. M., WHITMAN J. C. Is carotid intima-media thickness useful in cardiovascular disease risk assessment ? The Rotterdam Study. Circulation, 1997, 96 : 1432-1437.
9. O'LEARY D. H., POLAK J. F., KRONMAL R. A., MANOLIO T. A., BURKE G. L., WOLFSON S. K. Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med, 1999, 340 : 14-22.
10. BURKE G. L., EVANS G. W., RILEY W. A., SHARRETT A. R., HOWARD G., BARNES R. W., ROSAMOND W., CROW R. S., RAUTAHARJU P. M., HEISS G. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke, 1995, 26 : 386-91.
11. NORRIS J. W., ZHU C. Z., BORNSTEIN N. M., CHAMBERS B. R. Vascular risks of asymptomatic carotid stenosis. Stroke, 1991, 22 : 1485-1490.
12. NOVO S., TANTILLO R., CARUSO R., NOVO G., CICCONE M., STRANO A., MANSUETO S. Cardiovascular events and atherosclerosis progression and regression in a 5-years follow-up of patients with asymptomatic carotid plaque at first examination. Eur J Int Med, 1999, 10 (Suppl. 1) : S173/2.
13. BELCARO G., NICOLAIDES A. N., RAMASWAMI G., CESARONE M. R., DE SANCTIS M., INCANDELA L., FERRARI P., GEROULAKOS G., BARSOTTI A., GRIFFIN M., DHANJIL S., SABETAI M., BUCCI M., MARTINES G. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects : a 10-year follow-up study (the CAFES-CAVE study). Atherosclerosis, 2001, 156 : 379-87.
14. ZANCHETTI A., AGABITI ROSEI E., DAL PALÙ C., LEONETTI G., MAGNANI B., PESSINA A. The Verapamil in Hypertension and Atherosclerosis Study (VHAS) : results of long-term randomized treatment with either Verapamil or Clortalidone on carotid intimamedia thickness. J Hypertension, 1998, 16 : 1667-76.
15. BORHANI N. O., MERCURI M., BORHANI P. A., BUCKALEW V. M., CANOSSA-TERRIS M., CARR A. A., KAPPAGODA T., ROCCO M. V., SCHNAPER H. W., SOWERS J. R., BOND M. G. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA, 1996, 276 : 785-91.
16. ZANCHETTI A., BOND M. G., HENNING M., NEISS A., MANCIA G., DAL PALU C., HANSSON L., MAGNANI B., RAHN K. H., REID J. L., RODICIO J., SAFAR M., ECKES L., RIZZONI P. Calcium antagonism Lacipidine slows down progression of asymptomatic carotid atherosclerosis : principal results of the European Lacipidine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation, 2002, 106 : 2422-7.
17. PITT B., BYINGTON R. P., HUNNINGHAKE D. B., MANCINI G. B., MILLER M. E., RILEY W. (for the PREVENT Investigators). Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events. Circulation, 2000, 102 : 1503.
18. MCMAHON S., SHARPE N., GAMBLE G., CLAQUE A., MHURCHU C. N., CLARK T., HART H., SCOTT J., WHITE H. Randomized, placebo-controlled trial of the Angiotensin-converting enzyme inhibitor, Ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril. Am Coll Cardiol, 2000, 36 : 438-43.
19. LONN E. M., YUSUF S., DZAVIK V., QILONG Y., SMITH S., MOORE-COX A., BOSCH J., RILEY W. A., KOON K. T., for the SECURE Investigators. Effects of Ramipril and Vitamin E on Atherosclerosis Circulation, 2001, 103 : 919.
20. SMILDE T. J., VAN WISSEN S., WOLLERSHEIM H., TRIP M. D., KASTELEIN J. J., STALENHOEF A. F. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP) : a prospective, randomized, double-blind trial. Lancet, 2001, 357 (24) : 577-81.
21. FURBERG C. D., ADAMS H. P. JR., APPLEGATE W. B., BYINGTON R. P., ESPELAND M. A., HARTWELL T., HUNNINGHAKE D. B., LEFKOWITZ D. S., PROBSTFIELD J., RILEY W. A. et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation, 1994, 90 : 1676-87.
22. BYINGTON R. P., FURBERG C. D., CROUSE J. R. 3rd, Espeland MA, Bond MG. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am J Cardiol, 1995, 75 : 455-9.
23. HEDBLAD B., WIKSTRAND J., JANZON L., WEDEL H., BERGLUND G. Low-dose Metoprolol CR/XL and Fluvastatin slow progression of carotid intima-media thickness : Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation, 2001, 103 : 1721-6.
24. COTO V., OLIVIERO U., COCOZZA M., MILANI M. Long-term safety and efficacy of Picotamide, a dual-action antithromboxane agent, in diabetic patients with carotid atherosclerosis : a 6-year follow-up study. J Int Med, 1998, 26 : 200-5.
25. ZUSMAN R. M., CHESEBRO J. H., COMEROTA A., HARTMANN J. R., MASSIN E. K., RAPS E., WOLF P. A. Antiplatelet therapy in the prevention of ischemic vascular events : literature review and evidence-based guidelines for drug selection. Clin Cardiol, 1999, 22 : 559-73.
26. MACKEY A. E., ABRAHAMOWICZ M., LANGLOIS Y., BATTISTA R., SIMARD D., BOURQUE F., LECLERC J., COTE R. Outcome of asymptomatic patients with carotid disease. Asymptomatic Cervical Bruit Study Group. Neurology, 1997, 48 : 896-903.
27. Mayo. Asymptomatic Carotid Endarterectomy Study Group. Results of a randomized controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Clin Proc, 1992, 67 : 513-518.
28. AGEWALL S., FAGERBERG B., BERGLUND G., SCHMIDT C., WENDELHAG I., WIKSTRAND J. The Risk Factor Intervention Study Group, Sweden. Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-up. J Intern Med, 2001, 249 : 305-14.
29. MOORE W. S., KEMPCZINSKI R. F., NELSON J. J., TOOLE J. F. For the ACAS Investigators. Results of the Asymptomatic Carotid Atherosclerosis Study. Stroke, 1998, 29 : 2018-2025.
30. FINDLAY J. M., TUCKER W. S., FERGUSON G. G., HOLNESS R. O., WALLACE M. C., WONG J. H. Guidelines for the use of carotid endarterectomy: current recommendations from the Canadian Neurosurgical Society. CMAJ, 1997, 157 (15) : 653-9.
31. INZITARI D. The Italian Guidelines for stroke prevention. The Stroke Prevention and Educational Awareness Diffusion (SPREAD) Collaboration. Neurol Sci, 2000, 21 : 5-12.
32. BIASI G. M., FERRARI S. A., NICOLAIDES A. N., MINGAZZINI P. M., REID D. The ICAROS registry of carotid artery stenting. Imaging in Carotid Angioplasties and Risk of Stroke. J Endovasc Ther, 2001, 8 : 46-52.